Breaking News
Warrantless Surveillance Needs to Stop! A Call to Action
"Iran Was Our Best Ally in the Middle East" - Former Combat Pilot
Is AIPAC Influencing U.S. Policy? Michael T. Lester Questions Congressional Priorities
From Fatal Conceit to the Friendly Skies: How Deregulation Made Flight Affordable
Top Tech News
Researchers Turn Car Battery Acid and Plastic Waste into Clean Hydrogen and New Plastic
'Spin-flip' system pushes solar cell energy conversion efficiency past 100%
A Startup Has Been Quietly Pitching Cloned Human Bodies to Transfer Your Brain Into
DEYE 215kWh LiFePO4 + 125,000W Inverter + 200,000W MPPT = Run A Factory Offgrid!!
China's Unitree Unveils Robot With "Human-Like Physique" That Can Outrun Most People
This $200 Black Shaft Air Conditions Your Home For Free Forever -- Why Is It Banned in the U.S.?
Engineers have developed a material capable of self-repairing more than 1,000 times,...
They bypassed the eye entirely.
The Most Dangerous Race on Earth Isn't Nuclear - It's Quantum.
This Plasma Stove Cooks Hotter Than The Sun 
FDA Gives Emergency Authorization of Hydroxychloroquine Use
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the "off-label" drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.